2019
DOI: 10.1002/jcb.29155
|View full text |Cite
|
Sign up to set email alerts
|

Insights into the molecular regulatory network of pathomechanisms in osteochondroma

Abstract: Osteochondroma is a benign autosomal dominant hereditary disease characterized by abnormal proliferation of cartilage in the long bone. It is divided into solitary osteochondroma and hereditary multiple exostoses (HMEs). The exostosin‐1 (EXT‐1) and exostosin‐2 (EXT‐2) gene mutations are well‐defined molecular mechanisms in the pathogenesis of HME. EXT‐1 and EXT‐2 encode glycosyltransferases that are necessary for the synthesis of heparin sulfate. Accumulating evidence suggests that mutations in the EXT family … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 46 publications
0
9
0
Order By: Relevance
“…With respect to the origin of multiple hereditary osteochondromatosis, previous studies suggested that a mutation in the tumor suppressing genes exostosin glycosyltransferase 1 and exostosin glycosyltransferase 2 could be the cause of this pathology. These genes are responsible for the synthesis of heparan sulfate proteoglycans (HSPGs), thus any mutation would lead to a reduction in HSPGs synthesis, facilitating therefore the occurrence of multiple hereditary osteochondromatosis (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…With respect to the origin of multiple hereditary osteochondromatosis, previous studies suggested that a mutation in the tumor suppressing genes exostosin glycosyltransferase 1 and exostosin glycosyltransferase 2 could be the cause of this pathology. These genes are responsible for the synthesis of heparan sulfate proteoglycans (HSPGs), thus any mutation would lead to a reduction in HSPGs synthesis, facilitating therefore the occurrence of multiple hereditary osteochondromatosis (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…The fibroblast growth factor pathway is one of the pathways felt to be involved in the regulation of osteochondromas, but the exact mechanism is still being elucidated. HME has been associated with EXT‐1 and 2 mutations (Nielsen & Rosenberg, ), and a new article by Yang, Zhang, Lin, and Wang () describes how mice with EXT‐1 mutations have both impaired cartilage development and increased areas of differentiation. Histologically, DEH lesions are similar to osteochondromas seen in HME.…”
Section: Discussionmentioning
confidence: 99%
“…4 Most patients with HMO have a positive family history, and 90% have mutations in either the EXT1 or EXT2 gene. 5 , 6 …”
Section: Introductionmentioning
confidence: 99%